Key facts
- It has raised $580K.
- Notable investors include Groove Capital, Michele Hodges, Tracy Sher, University Enterprise Laboratories.
- Pelva Health has filed 1 Form D with the SEC, most recently Jun 2024 ($82K sold to 3 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Pelva Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Pelva Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pelva Health
Manufacturer of vaginal liners designed for intimate use. The company's platform offers single-use, water-based hydrogel inserts applied before penetration that create a cushioned layer, include applicators and instructions, are formulated without silicones, plastics, latex, glycerin, parabens, or fragrances, use plant-based materials, align with typical vaginal pH ranges, and are positioned for use during intercourse, therapy, or training, enabling adult consumers seeking comfort during penetration to reduce friction, support sensitive tissue, and manage insertion discomfort through a physical barrier that moves with the body.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Edina, MN, United States
- Founded
- 2023
- Employees
- 6
- Website
- pelva.com/
- Ownership
- Privately Held (backing)
Pelva Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pelva Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pelva Health in its N-PORT filings yet. We sweep new filings monthly.